Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 3Unknown 2Recruiting 2Withdrawn 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vulvar Neoplasms 2Ovarian Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Soft Tissue Neoplasms 1Skull Base Neoplasms 1Gastric Adenocarcinoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Bone Neoplasms 1Anastomotic Leak 1

Interventions

Oxaliplatin 14sintilimab 10S 1 (combination) 9Drug Therapy 7Capecitabine 5tislelizumab 4Surgical Procedures, Operative 4Paclitaxel 4HMPL-013 4apatinib 3Tegafur 3Immune Checkpoint Inhibitors 3Cisplatin 3Bevacizumab 3surufatinib 2potassium oxonate 2lenvatinib 2irinotecan sucrosofate 2gimeracil 2Observation 2Injections 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorouracil 2Exercise 2Endoscopic Mucosal Resection 2Doxorubicin 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zolbetuximab 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Stomach Neoplasms × Indocyanine Green × Clear all
NCT04973475 2021-07-22

Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer

Fujian Medical University

Phase 2 Not yet recruiting
180 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡